266 related articles for article (PubMed ID: 8012724)
1. Comparison of the haemodynamic profiles of elgodipine and nicardipine in the anaesthetized dog.
Drieu la Rochelle CD; Grosset A; O'Connor SE
Br J Pharmacol; 1994 Jan; 111(1):49-56. PubMed ID: 8012724
[TBL] [Abstract][Full Text] [Related]
2. The central and regional cardiovascular responses to intravenous and intracoronary administration of the phenyldihydropyridine elgodipine in anaesthetized pigs.
Sassen LM; Soei LK; Koning MM; Verdouw PD
Br J Pharmacol; 1990 Feb; 99(2):355-63. PubMed ID: 2328400
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular effects of the new dihydropyridine derivative elgodipine.
Tamargo J; López-Sendón J; Delpón E; González-Morales M; de Miguel E
Arzneimittelforschung; 1991 Sep; 41(9):895-900. PubMed ID: 1796916
[TBL] [Abstract][Full Text] [Related]
4. Effects of the new dihydropyridine derivative 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester on the cardiohemodynamics and the energy metabolism of ischemic myocardium.
Imai H; Matsui K; Ochi S; Nakazawa M; Nakagawa Y; Imai S
Arzneimittelforschung; 1987 Dec; 37(12):1348-52. PubMed ID: 3449062
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular effects of OPC-13340, a potent, long-acting 1,4-dihydropyridine calcium channel blocker, in dogs.
Mori T; Nakayama N; Ohura M; Ikezono K; Kinoshita S; Kamata M; Hosokawa T; Yamashita S; Yabuuchi Y
Arch Int Pharmacodyn Ther; 1993; 321():41-56. PubMed ID: 8323415
[TBL] [Abstract][Full Text] [Related]
6. Comparison of haemodynamic responses to cilnidipine and nicardipine in an experimental model of acute congestive heart failure.
Noguchi K; Matsuzaki T; Koyama T; Itomine T; Sakanashi M
Clin Exp Pharmacol Physiol; 1998; 25(7-8):541-7. PubMed ID: 9673425
[TBL] [Abstract][Full Text] [Related]
7. Haemodynamic effects of hypotension induced by KRN2391 and nicardipine in isoflurane anaesthetized dogs.
Takeda S; Ozawa Y; Tomaru T
Can J Anaesth; 1997 Sep; 44(9):1002-7. PubMed ID: 9305565
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular effects of elgodipine and nifedipine compared in anaesthetized rats.
Valdivielso JM; Macías JF; López-Novoa JM
Eur J Pharmacol; 1997 Sep; 335(2-3):193-8. PubMed ID: 9369373
[TBL] [Abstract][Full Text] [Related]
9. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular profile of FPL 62129, a novel dihydropyridine calcium channel blocker, in anaesthetised dogs: a comparison with nifedipine.
Humphries RG; O'Connor SE
J Cardiovasc Pharmacol; 1988 Mar; 11(3):332-8. PubMed ID: 2452927
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic effects of a dihydropyridine calcium antagonist, NB-818 (NPK-1886) in anesthetized dogs.
Nishikibe M; Nagura J; Kamei K; Fukuroda T
Arch Int Pharmacodyn Ther; 1988; 291():7-20. PubMed ID: 3365068
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological profile of nicardipine hydrochloride in anesthetized dogs with acute heart failure. Part 1: Hemodynamic effects in normal dogs and dogs with acute heart failure.
Saitoh C; Momose K; Tanaka H; Sato S; Taguchi K; Saitoh M; Maehara J; Asano M; Usuda S
Arzneimittelforschung; 1998 Feb; 48(2):125-32. PubMed ID: 9541721
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic and antiischemic effects of intravenous elgodipine, a new dihydropyridine calcium channel blocker, in patients with chronic stable angina.
Kuhn A; Carlsson J; Miketic S; Tebbe U
Cardiovasc Drugs Ther; 1995 Aug; 9(4):595-600. PubMed ID: 8547210
[TBL] [Abstract][Full Text] [Related]
14. Effects of nicardipine, a dihydropyridine calcium antagonist, on regional myocardial blood flow, myocardial oxygen tension, and electrical abnormalities during acute coronary artery occlusion in dogs.
Hashimoto H; Asano M; Takiguchi Y; Katoh H; Nakashima M
J Cardiovasc Pharmacol; 1985; 7(4):613-21. PubMed ID: 2410698
[TBL] [Abstract][Full Text] [Related]
15. Haemodynamic effects of intravenous nicardipine during upright exercise in patients with stable angina pectoris.
Jackson NC; Silke B; Verma SP; Reynolds G; Hafizullah M; Taylor SH
Postgrad Med J; 1984; 60 Suppl 4():11-6. PubMed ID: 6527973
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular effects of the new generation calcium antagonist 3-pyridine carboxylic acid 5-[(cyclopropylamino)carbonyl]-1,4-dihydro-2,6-dimethyl-4-(2-nitropheny l) octyl ester.
Hojo M; Teramoto N; Hata H; Katayama O; Tatsumi H; Shibata S
Arzneimittelforschung; 1992 May; 42(5):621-8. PubMed ID: 1530674
[TBL] [Abstract][Full Text] [Related]
17. Effects of calcium antagonists, felodipine and nicardipine, on cerebral circulation in dogs.
Tanaka M; Yoshida Y; Mitomi A; Nakazawa M; Imai S
Jpn J Pharmacol; 1990 Feb; 52(2):273-9. PubMed ID: 2313936
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular actions of the dihydropyridine calcium antagonist nimodipine in the dog.
Satoh K; Kawada M; Wada Y; Taira N
Arzneimittelforschung; 1984; 34(5):563-8. PubMed ID: 6540573
[TBL] [Abstract][Full Text] [Related]
19. Haemodynamic effects of a new dihydropyridine calcium entry blocker, S-12968-(-), in a rat model of cardiovascular calcium overload.
Makki T; Lartaud I; Bray-des Boscs L; Capdeville-Atkinson C; Chillon JM; Hoffman M; Nicolas JP; Atkinson J
Br J Pharmacol; 1992 May; 106(1):79-84. PubMed ID: 1324069
[TBL] [Abstract][Full Text] [Related]
20. Reconsideration of vascular selectivity of dihydropyridine calcium antagonists: comparison of cardiovascular profile of mepirodipine, a novel dihydropyridine consisting of a single stereoisomer with (+)-(S)-(S) conformation, with those of nifedipine and nicardipine.
Motomura S; Hashimoto K
Jpn J Pharmacol; 1990 Feb; 52(2):319-30. PubMed ID: 2313939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
